Market revenue in 2020 | USD 27,156.6 million |
Market revenue in 2028 | USD 44,668.9 million |
Growth rate | 6.4% (CAGR from 2020 to 2028) |
Largest segment | Diabetic retinopathy |
Fastest growing segment | Eye Allergy & Infection |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Dry Eye Syndrome, Glaucoma, Eye Allergy & Infection, Diabetic Retinopathy, Diabetic-associated Macular Degeneration, Uveitis, Cataract, Diabetic Macular Edema, Other Application |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetes associated ophthalmic treatment market will help companies and investors design strategic landscapes.
diabetic retinopathy was the largest segment with a revenue share of 26.43% in 2020. Horizon Databook has segmented the Global diabetes associated ophthalmic treatment market based on dry eye syndrome, glaucoma, eye allergy & infection, diabetic retinopathy, diabetic-associated macular degeneration, uveitis, cataract, diabetic macular edema, other application covering the revenue growth of each sub-segment from 2017 to 2028.
Horizon Databook provides a detailed overview of global-level data and insights on the Global diabetes associated ophthalmic treatment market, including forecasts for subscribers. This global databook contains high-level insights into Global diabetes associated ophthalmic treatment market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account